BRIEF published on 04/24/2025 at 07:39, 1 year 4 months ago Getlink : Chiffre d’affaires en baisse de 17% au premier trimestre 2025 Chiffre D'affaires Obligations Vertes Getlink ElecLink Eurotunnel
BRIEF published on 04/24/2025 at 07:39, 1 year 4 months ago Getlink: Revenue down 17% in the first quarter of 2025 Turnover Green Bonds Getlink ElecLink Eurotunnel
BRIEF published on 04/24/2025 at 07:35, 1 year 4 months ago Evotec and Bristol Myers Squibb's Protein Degradation Partnership Yields Progress Evotec SE Oncology Research Bristol Myers Squibb Molecular Glue Degraders $75 Million Payment
BRIEF published on 04/24/2025 at 07:35, 1 year 4 months ago Le partenariat entre Evotec et Bristol Myers Squibb pour la dégradation des protéines génère des progrès Evotec SE Recherche En Oncologie Bristol Myers Squibb Dégradeurs De Colle Moléculaire Paiement De 75 Millions De Dollars
BRIEF published on 04/24/2025 at 07:35, 1 year 4 months ago Record Order Backlog Highlights Vossloh's Robust Q1/2025; Positive Outlook Maintained EBIT Order Backlog Financial Outlook Vossloh Q1 2025
BRIEF published on 04/24/2025 at 07:35, 1 year 4 months ago Un carnet de commandes record souligne le solide premier trimestre 2025 de Vossloh ; les perspectives positives sont maintenues EBIT Vossloh Perspectives Financières Carnet De Commandes T1 2025
BRIEF published on 04/24/2025 at 07:30, 1 year 4 months ago Delivery Hero Maintains 2025 Forecast Following Strong Q1 Performance Delivery Hero GMV Growth Technological Advancements 2025 Guidance Q1 2025 Results
BRIEF published on 04/24/2025 at 07:30, 1 year 4 months ago Delivery Hero maintient ses prévisions pour 2025 après de solides performances au premier trimestre Héros De La Livraison Progrès Technologiques Croissance Du GMV Orientations Pour 2025 Résultats Du Premier Trimestre 2025
BRIEF published on 04/24/2025 at 07:21, 1 year 4 months ago Heidelberg Pharma AG's First Quarter Financial Report for 2025 Financial Statement Clinical Trials Heidelberg Pharma 2025 Outlook ADC Programs
BRIEF published on 04/24/2025 at 07:21, 1 year 4 months ago Rapport financier du premier trimestre 2025 de Heidelberg Pharma AG Essais Cliniques Heidelberg Pharma Perspectives 2025 État Financier Programmes ADC
Published on 09/10/2026 at 22:25, 5 hours 55 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 13 hours ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 13 hours 20 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 00:05, 4 hours 14 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 4 hours 18 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 5 hours 40 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 6 hours 9 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 6 hours 12 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/10/2026 at 19:30, 8 hours 50 minutes ago Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 19:30, 8 hours 50 minutes ago Mise à disposition du Rapport Financier Semestriel 2026
Published on 09/10/2026 at 18:10, 10 hours 10 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Published on 09/10/2026 at 17:45, 10 hours 35 minutes ago COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Published on 09/10/2026 at 17:42, 10 hours 37 minutes ago Déclaration d'actions et de droits de vote au 31.08.2026
